Bristol-Myers’ Opdivo fails to meet lung cancer study goal

REUTERS: Bristol-Myers Squibb Co said on Friday its blockbuster cancer drug Opdivo failed to meet the main goal in patients with a type of lung cancer, that had relapsed after chemotherapy.

The late-stage study was testing Opdivo against the current standard of care, chemotherapy, in patients suffering from small cell lung cancer, an aggressive form of the disease.

FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headqu

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

READ  Australia court rules Heinz 'healthy' toddler food misleading